June 4, 2019 / 8:31 PM / 4 months ago

BRIEF-Emergent Announces FDA Approval Of Change In Storage Conditions And Transfer Of Manufacturing For Its Cholera Vaccine

June 4 (Reuters) - Emergent BioSolutions Inc:

* EMERGENT BIOSOLUTIONS ANNOUNCES FDA APPROVAL OF CHANGE IN STORAGE CONDITIONS AND TRANSFER OF MANUFACTURING FOR ITS CHOLERA VACCINE

* EMERGENT BIOSOLUTIONS - ANNOUNCED APPROVAL BY FDA OF PRIOR APPROVAL SUPPLEMENT SUBMITTED BY CO FOR ITS ORAL CHOLERA VACCINE, VAXCHORA

* EMERGENT BIOSOLUTIONS - VAXCHORA PRIOR APPROVAL SUPPLEMENT SUPPORTS CHANGE IN STORAGE CONDITIONS OF THE VACCINE FROM FROZEN TO REFRIGERATED AT 2-8°C

* EMERGENT BIOSOLUTIONS - VAXCHORA PRIOR APPROVAL SUPPLEMENT SUPPORTS TRANSFER OF THE BULK DRUG SUBSTANCE MANUFACTURING TO MANUFACTURING FACILITY IN BERN Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below